Junichiro Watanabe

22PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 27, 2026
Prognostic performance of the Japanese Breast Cancer Society pathological response classification after neoadjuvant chemotherapy.

|Oct 24, 2026
Late-Onset Radiation-Induced Leukoencephalopathy in a Long-Term Survivor with HER2-Positive Breast Cancer and Brain Metastases: A Case Report.

|Sep 28, 2026
Clinical and Local Immune Factors Associated With Pleurodesis Outcomes in Breast Cancer Patients With Malignant Pleural Effusion: A Retrospective Study.

|Jun 26, 2026
Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.

|Mar 26, 2026
Sacituzumab govitecan in Japanese participants with HR+/HER2- metastatic breast cancer: primary results from the phase II ASCENT-J02 study.

Akihiko Shimomura, Takahiro Kogawa, Koji Matsumoto

|Mar 13, 2026
Clinical Outcomes and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A Real-World Data Analysis.

Moe Itakura, Yoshiya Horimoto, Yumiko Ushiyama

Pageof 4

Frequent Collaborators

11 joint publications

Yoshiya Horimoto

5 joint publications

Yumiko Ishizuka

3 joint publications

Takuo Hayashi

3 joint publications

Shogo Nakamoto